Cornerstone Planning Group LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1822587 FAIRFIELD, NJ

Position in VRTX

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$51,798

-$4,418 QoQ

Shares Held

116

-6.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cornerstone Planning Group LLC holds $285,266 across 38 Biotechnology names. VRTX ranks #1 (18.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	116	$51,798
2	ALNY	Alnylam Pharmaceuticals, Inc.	100	$33,087
3	REGN	Regeneron Pharmaceuticals, Inc.	35	$27,042
4	RPRX	Royalty Pharma plc	402	$19,283
5	RVMD	Revolution Medicines, Inc.	194	$18,866
6	HALO	Halozyme Therapeutics, Inc.	287	$18,548
7	CRSP	CRISPR Therapeutics AG	300	$14,271
8	ARGX	Argenx SE	15	$10,953

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$51,798	116	-6.5%	Shares	Sole	2026-05-06
2025-12-31	$56,216	124	+6.0%	Shares	Sole	2026-02-02
2025-09-30	$45,821	117	+1.7%	Shares	Sole	2025-11-04
2025-06-30	$51,198	115	-8.0%	Shares	Sole	2025-08-11
2025-03-31	$60,602	125	+111.9%	Shares	Sole	2025-04-30
2024-12-31	$23,759	59	+1.7%	Shares	Sole	2025-01-29
2024-09-30	$26,974	58	-26.6%	Shares	Sole	2024-11-05
2024-06-30	$37,028	79	-13.2%	Shares	Sole	2024-08-13
2024-03-31	$38,038	91	-34.1%	Shares	Sole	2024-05-07
2023-12-31	$56,150	138	+43.8%	Shares	Sole	2024-02-12
2023-09-30	$33,383	96	+1.1%	Shares	Sole	2023-11-08
2023-06-30	$33,431	95	+120.9%	Shares	Sole	2023-08-15
2022-12-31	$12,417	43	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.